GlassScriptPhysician profile
Robert C Dews
NPI 1194926766
$6,739.07
in general payments reported to CMS, 2019-2025
12 companies · $1,062 in 2025
The $1,062 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.86 · 2020: $542 · 2021: $2,319 · 2022: $111 · 2023: $557 · 2024: $2,130 · 2025: $1,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,379 · Food and Beverage: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,378.98 |
| Food and Beverage | $1,369.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,009.55 | 2021-2024 | |
| Alon Medical Technology | $1,869.81 | 2020-2024 | |
| Smith+Nephew, INC. | $1,044.81 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Aetos Shoulder System, Microraptor |
| Stryker Corporation | $321.43 | 2019-2024 | Reunion, Axsos |
| Zimmer Biomet Holdings, INC. | $174.15 | 2023 | Tapestry, Comprehensive Shoulder System |
| Depuy Synthes Sales INC. | $80.06 | 2022 | |
| Boston Scientific Corporation | $68.10 | 2021-2023 | |
| Illuminoss Medical, INC. | $66.52 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
| Catalyst Orthoscience | $44.71 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $31.34 | 2024-2025 | |
| Bioventus LLC | $15.35 | 2023 | Durolane |
| Kowa Pharmaceuticals America, INC. | $13.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.